Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 591 entries
View as:

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00112827 Org: User:
Start: 11/30/04 End: 02/15/19 Due: 02/15/20

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients with Relapsed or Refractory Grade 1-3a Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06453044 Org: User:
Start: 09/09/24 End: 03/14/28 Due: 03/14/29

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT06196008 Org: User:
Start: 12/05/23 End: 05/16/28 Due: 05/16/29

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT01314677 Org: User:
Start: 04/30/11 End: 06/30/12 Due: 06/30/13

Denosumab for Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06524960 Org: User:
Start: 09/03/24 End: 04/11/26 Due: 04/11/27

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06763328 Org: User:
Start: 12/16/24 End: 06/16/29 Due: 06/16/30

Family Caregivers in Underserved Populations Providing Complex Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT05213078 Org: User:
Start: 07/15/20 End: 03/09/22 Due: 03/09/23

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00544830 Org: User:
Start: 07/18/06 End: 03/09/26 Due: 03/09/27

Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02345798 Org: User:
Start: 02/11/15 End: 05/25/17 Due: 05/25/18

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT07040982 Org: User:
Start: 05/01/26 End: 06/13/28 Due: 06/13/29

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06731894 Org: User:
Start: 10/27/25 End: 10/27/26 Due: 10/27/27

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02119468 Org: User:
Start: 06/30/14 End: 12/01/22 Due: 12/01/23

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01116154 Org: User:
Start: 05/31/10 End: 08/31/10 Due: 08/31/11

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03438344 Org: User:
Start: 12/31/18 End: 12/31/21 Due: 12/31/22

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01741636 Org: User:
Start: 01/31/13 End: 12/31/13 Due: 12/31/14

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06780787 Org: User:
Start: 05/20/25 End: 11/05/27 Due: 11/05/28

Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03057795 Org: User:
Start: 04/03/17 End: 03/25/26 Due: 03/25/27

Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06922604 Org: User:
Start: 09/23/25 End: 02/22/28 Due: 02/22/29

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05363111 Org: User:
Start: 11/22/22 End: 02/24/26 Due: 02/24/27

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01199562 Org: User:
Start: 12/31/10 End: 12/15/25 Due: 12/15/26

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01267812 Org: User:
Start: 10/03/11 End: 11/02/20 Due: 11/02/21

Brentuximab Vedotin and Nivolumab for the Treatment of Patients with Relapsed/refractory Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04561206 Org: User:
Start: 11/12/21 End: 10/02/26 Due: 10/02/27

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06476067 Org: User:
Start: 01/01/06 End: 12/31/25 Due: 12/31/26

Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00720876 Org: User:
Start: 07/23/08 End: 06/08/17 Due: 06/08/18

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT01159067 Org: User:
Start: 07/31/10 End: 08/09/11 Due: 08/09/12